Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL)'s conditional sale of its 100%-owned 12.2MWac solar plant to CrossBoundary Energy (CBE) for a US$8.1million profit on construction cost frees up cash for potentially higher return investments, says broker Panmure Liberum.
Completion of the sale will take a few months but, importantly, the plant will continue to supply Caledonia’s 64%-owned Blanket mine under an exclusive power purchase agreement.
Adidas AG's (OTCQX:ADDYY) doomed collaboration with cancelled US rapper Kanye West, aka Yeezy, remains a significant burden for the German sportswear brand, according to Barclays.
In a research note, Barclays analysts predicted ongoing write-down headwinds to feature in adidas’ upcoming third-quarter results.
UK banks remain attractive investment opportunities despite recent challenges, according to UBS.
A mixed picture for lenders was highlighted by the investment bank, with benefits for the sector from a stable base of customer deposits but facing pressure due to policy changes and potential future tax increases.
Like a piping hot cheese and onion bake fresh from an industrial-sized oven, Greggs PLC (LSE:GRG)’s third-quarter results were not everyone’s cup of tea, but they provided a quick calorie hit to keep investors sated for now.
Moving on from that clunky analogy, Barclays PLC (LSE:BARC) acknowledged that despite the strong business model and ongoing growth via new stores, investors may focus on the softer third-quarter performance.
3i Group PLC (LSE:III) shares fell further on Tuesday, extended losses after hedge fund Shadowfall revealed a short position over the weekend.
Analysts at Citi said they believe that "the concerns are overdone" and retained a 'high-conviction buy' rating and 4,140p target price versus the last close at 3,305p.
UBS has reiterated its buy rating on Haleon PLC (LSE:HLN, NYSE:HLN) shares after news that former parent company Pfizer Inc (NYSE:PFE, ETR:PFE) further pared down its stake in the FTSE 100-listed Sensodyne and Panadol maker.
Haleon, which comprises the former consumer divisions of Pfizer and GSK PLC (LSE:GSK, NYSE:GSK), agreed on an off-market purchase of approximately £230 million worth of its own shares after Pfizer said it was cutting its stake by around £2.1 billion.
Currys PLC (LSE:CURY)'s recent Nordic assets investor day showcased what a high-quality business Elkjop is, according to Panmure Liberum.
the broker highlighted that Elkjop is a market leader with a 28% share.
Rio Tinto Ltd (LSE:RIO, ASX:RIO, OTC:RTNTF);s Canadian aluminium assets are world-class, under-appreciated assets and make a key differentiator in the investment case for the mining giant, says broker Jefferies.
During a visit to its upgraded AP60 plant, Rio predicted North American aluminium demand (both primary and recycled) would grow at 4% compound annually through 2028.
GSK PLC (LSE:GSK, NYSE:GSK) respiratory syncytial virus (RSV) vaccine, Arexvy, faces challenges that could impact its financial future, according to a report by Jefferies.
The jab is designed to protect older adults from RSV, a common virus that can lead to severe respiratory infections. It has shown potential, but recent data suggest GSK may need to reduce its sales expectations, according to the US investment bank.
Ceres Power Holdings PLC (LSE:CWR, OTC:CPWHF) has been highlighted as a “de-risked” player in the green hydrogen market after announcing a cost-cutting plan in half-year results last month.
UBS analysts said in a note this showed Ceres was over its peak investment in the likes of research and meant further fundraising to develop its hydrogen fuel cells was not needed.
Analysts at broker Peel Hunt remain impressed by hVIVO PLC's (AIM:HVO) unique offering in the human challenge trial segment and the rapid diversification of its services.
The broker's view comes in light of hVIVO’s launch of the full suite of its hLAB standalone services, expanding its virology and immunology laboratory offerings.